In addition, it has been found that ubiquitin-specific protease 4 (USP4) plays a tumor-promoting role in PAAD and can be used as a prognostic indicator and therapeutic target in patients with PAAD resection [15]. Here, USP4 is linked to pancreatic adenocarcinoma.